Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression
Parkman, Gennie L, Turapov, Tursun, Kircher, David A, Burnett, William J, Stehn, Christopher M, O'Toole, Kayla, Culver, Katie M, Chadwick, Ashley T, Elmer, Riley C, Flaherty, Ryan, Stanley, Karly A, Foth, Mona, Lum, David H, Judson-Torres, Robert L, Friend, John E, VanBrocklin, Matthew W, McMahon, Martin, Holmen, Sheri L
Published in Molecular cancer therapeutics (04.03.2024)
Published in Molecular cancer therapeutics (04.03.2024)
Get full text
Journal Article
Abstract 4127: Combined inhibition of RAF, MEK, and FAK attenuates melanoma brain metastases and prolongs survival in preclinical models
Stanley, Karly A., Almazan, Jared D., Turapov, Tursun, Kircher, David A., Parkman, Gennie L., Field, MiKaela N., Culver, Katie M., Stehn, Christopher M., Coma, Silvia, Pachter, Jonathan A., Colman, Howard, Holmen, Sheri L.
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 427: Newer generation mTOR inhibition represents effective therapeutic strategy for BRAF-mutant melanoma
Parkman, Gennie L., Turapov, Tursun, Kircher, David, Burnett, William, Stehn, Christopher, O'Toole, Kayla, Culver, Katie, Chadwick, Ashley, Elmer, Riley, Flaherty, Ryan, Foth, Mona, Stanley, Karly, Andtbacka, Robert, Lum, David, Judson-Torres, Robert, McMahon, Martin, Holmen, Sheri
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article